Baseline demographic characteristics and clinical variables of enrolled patients
Variables | Training Cohort (n = 161) | Validation Cohort (n = 175) | P Value | ||||
---|---|---|---|---|---|---|---|
Good Outcome (n = 110) mRS (0–2) | Poor Outcome (n = 51) mRS (3–6) | P Value | Good Outcome (n = 98) mRS (0–2) | Poor Outcome (n = 77) mRS (3–6) | P Value | ||
Age (mean) (yr) | 65.7 (SD, 11.65) | 63.76 (SD, 13.51) | .45 | 66.76 (SD, 12.45) | 66.96 (SD, 13.28) | .83 | .20 |
Male (No.) (%) | 69 (62.73) | 34 (66.67) | .76 | 68 (69.39) | 48 (62.34) | .41 | .66 |
History (No.) (%) | |||||||
Hypertension | 90 (81.82) | 41 (80.39) | 1.00 | 71 (72.45) | 54 (70.13) | .87 | .05 |
Hyperlipidemia | 36 (32.73) | 16 (31.37) | 1.00 | 23 (23.47) | 25 (32.47) | .25 | .33 |
Diabetes | 34 (30.91) | 19 (37.25) | .54 | 25 (25.51) | 24 (31.17) | .51 | .33 |
Smoking | 21 (19.09) | 15 (29.41) | .21 | 23 (23.47) | 16 (20.78) | .81 | .99 |
Atrial fibrillation | 74 (67.27) | 24 (47.06) | .02 | 69 (70.41) | 42 (54.55) | .05 | .63 |
Coronary heart disease | 22 (20.00) | 7 (13.73) | .46 | 16 (16.33) | 14 (18.18) | .90 | .83 |
NIHSS score (mean) | 14.26 (SD, 8.45) | 14.51 (SD, 8.24) | .92 | 14.32 (SD, 7.57) | 15.27 (SD, 6.90) | .19 | .64 |